Neurovations

Navigating Pain Management in California Workers Comp System During COVID 19
2020-05-21 09:30 - 11:30 (America/Los_Angeles)
Register Here!

Dr. Steven Feinberg: Feinberg Medical Group, Adjunct Clinical Professor Stanford‘DWC’s Executive Orders, Treatment & Medical Legal Evaluations with Telemedicine’

Dr. Annu Navani: Medical Director Comprehensive Spine & Sports Ctr, Adjunct Assoc. Clinical Professor, Stanford. ‘Telehealth Treatments in Workers Compensation, Clinical and Business Administration’

Q & A Session: Dr. Lynn Cintron (CALSIPP President), Dr. Steven Feinberg, Dr. Annu Navani, Dr. Jacob Rosenberg (CSIMS), Mr. Steve Cattolica (Advocal), Glenn Olsen Esq. (Laughlin & Falbo)

Neuromodulation for the COVID-19 Cytokine Storm
2020-05-28 17:30 - 18:30
Register Here!

Join Eric J. Grigsby, MD, MBA and Peter Staats, MD, MBA for a conversation exploring Neuromodulation for the COVID-19 Cytokine Storm

Learn:

-The potential of non-invasive Vagus Nerve Stimulation (nVNS) therapy to address COVID-19 induced cytokine storm.

-Preliminary observations and a strong scientific foundation suggest that nVNS might provide clinical benefits in patients with COVID‐19 via multiple mechanisms.

Neuromodulation, Neuroscience, and Digital Health
2020-06-25 17:30 - 18:30
Patient-centric Innovation in Chronic Pain Therapies

Complimentary Registration

Join CEO and Founder of Neurovations, Dr. Eric Grigsby, and the Director of R&D Applied Research at Abbott Neuromodulation, Dr. Erika Ross, for an in-depth discussion on patient-centric innovations in chronic pain therapies. During this webinar, Dr. Ross will discuss her team’s research in building patient-centric neuromodulation therapies and discuss ways in which digital health can be leveraged to provide truly patient-centric chronic pain neuromodulation therapies.

About Eric Grigsby, MD, MBA

Dr. Eric Grigsby is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

About Erika Ross, Phd

Erika is the Director of Applied Research at Abbott Neuromodulation, leading applied research strategy, external partnerships, portfolio, and execution. Applied research includes computational modeling, pre-clinical, feasibility, and clinical safety trials that feed new products and indications.

Prior to her role at Abbott, Erika was the Neuroscience Director at Cala Health, a Stanford Biodesign incubated start-up that has been developing a non-invasive, digitally-enabled neuromodulation solution for Essential Tremor patients. She held roles of increasing leadership at Cala Health as the company completed development and prepared for commercialization and played a major role in developing their digital health architecture and team.

Prior to Cala Health, Erika was an Assistant Professor in Neurologic Surgery and the Deputy Director of the Surgical Device Innovation Accelerator at the Mayo Clinic where she developed invasive and non-invasive solutions for unmet patient needs in the neuromodulation and other surgical practice areas.

Are You Addressing Inclusion and Equity in Pain Management?
2020-07-02 17:30 - 18:30
Complimentary Registration

Join CEO and Founder of Neurovations, Dr. Eric Grigsby, and Professor and Director of Neuromodulation Services at UCSF, Dr. Lawrence Poree, for an in-depth conversation on equity and inclusion in pain management.

The conversation will include:

-Identifying and stopping patient bias

-Breaking down bias in the workplace

Additional Resources:

–HHS Action Plan to Reduce Racial and Ethnic Health Disparities

–A Practical Guide to Implementing the National CLAS Standards: For Racial, Ethnic and Linguistic Minorities, People with Disabilities and Sexual and Gender Minorities

–Reducing Racial Health Care Disparities: A Social Psychological Analysis

About Eric Grigsby, MD, MBA

Dr. Eric Grigsby is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

About Lawrence Poree, MD, PhD. MPH

Dr. Lawrence Poree holds the position of Clinical Professor in the Department of Anesthesia at the University of California at San Francisco (UCSF) where he serves as the Director of the Neuromodulation service.

Dr. Poree began his neuromodulation career as a basic science researcher at UC Berkeley where he investigated the analgesic properties of CNS hormones as part of his doctoral thesis. He continued his research in neuromodulation at Johns Hopkins University in the department of Biomedical Engineering where he investigated the neural pathways involved in spinal cord stimulation and the sympathetic nervous system. He decided to apply his research to medical practice and enrolled at Stanford University where he earned his medical degree and completed his residency in anesthesia while continuing to conduct research on the analgesic properties of alpha-2 agonists. He then completed an interventional pain fellowship at UCSF.

He founded and served as medical director of a private practice comprehensive pain management clinic for the next 15 years. During this time, he consulted for various neuromodulation companies in the development of novel neuromodulation devices. He returned to academia to head the neuromodulation program at the University Of California at San Francisco Pain Management Center.

For the past 8 years he has served on the North American Neuromodulation Society (NANS) Board of Directors. He also serves on the California Society of Interventional Pain Physicians and the International Neuromodulation (CASIPP) Board of Directors.

Electrical Activation of Neural Reflexes for the Treatment of Autoimmune Diseases
2020-07-16 17:30 - 18:30
Complimentary Registration

Join CEO and Founder of Neurovations Dr. Eric Grigsby and Chief Medical Officer of Setpoint Dr. David Chernoff for an in-depth discussion on the activation of neuroimmune reflexes by Vagus Nerve Stimulation which reduced disease activity in a proof-of-concept study in Rheumatoid Arthritis. Rheumatoid Arthritis is an autoimmune disease that leads to permanent joint destruction and accelerated mortality requiring lifelong immunosuppressive therapies.

Complimentary Registration

CEO and Founder of Neurovations Dr. Eric Grigsby

Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

Chief Medical Officer @SetPoint Medical David Chernoff, MD

lDavid Chernoff has 25 years of molecular diagnostics and biopharmaceutical experience and has served as a translational medicine consultant to more than 40 biopharma and device companies. He has held chief medical officer posts with a number of venture capital backed diagnostic and therapeutic companies. He was formerly VP of Corp Technology at Elan Pharma and Medical Director at Chiron Corp.

The 27th Napa Pain Conference Online
2020-08-15 08:00 - 17:30
Enjoy Complimentary Registration and CME

Learn More

Since its establishment in 1990 by Dr. Eric J. Grigsby, the Napa Pain Conference has set the bar for quality education, breaking research, and networking. This is your opportunity to connect with the leaders in pain management.

With a world-class Program Committee, unrivaled keynote speakers, and dynamic presentations, the Napa Pain Conference presents the latest information in pain management and has become a forum to:

Discuss the treatment of painEstablish best practicesLearn and review emerging treatment options

Differential Target Multiplexed (DTM™) Spinal Cord Stimulation (SCS) – What is it and how does it work?
2020-09-10 17:30 - 18:30
Join CEO and Founder of Neurovations Dr. Eric Grigsby and Co-founder and Director of Research at Millennium Pain Center, Dr. Ricardo Vallejo for a deep dive into how a hypothesis can change the way we think about SCS therapies and optimizing outcomes. Dr. Vallejo will unpack the questions necessary to get to a truer understanding of the effects of SCS.

Complimentary Registration

CEO and Founder of Neurovations Dr. Eric Grigsby

Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

Co-founder and Director of Research, Dr Ricardo Vallejo

Dr. Ricardo Vallejo is the Director of Research at Millennium Pain Center. He is deeply committed to discovering new methods and treatments for chronic pain. Dr. Vallejo holds multiple appointments in the editorial boards of international peer review journals such as Clinical Journal of Pain, Pain Physicians, Journal of Opioid Management and Revista Mexicana de Anestesiologia.

Dr. Vallejo is the current Associate Editor of the journal Pain Practice, where he established the section Images in Pain Practice in 2007. He is also member of the examination board for the World Institute of Pain. Dr. Vallejo has published extensively in national and international peer review journals and serves as speaker in meetings around the world. He is adjunct professor at the Illinois State University. Research interests of Dr. Vallejo include management of chronic pain status, such as sympathetically maintained pain: failed back surgery, and discogenic low back pain. His research efforts are aimed at understanding the immune mechanisms underlying neuropathic pain conditions and the effects of electrical stimulation on the central and peripheral immune response.

Dr. Vallejo received his medical degree in Colombia and then pursued his PhD in Immunology at the Complutense University in Madrid Spain. During his residency in Anesthesiology at the University of Miami he became Chief Residence of the program and served as resident representative for the Florida Society of Anesthesiology and The American Society of Anesthesiology. Dr. Vallejo then pursued his fellowship in Pain Medicine at Harvard Medical School at Massachusetts General Hospital. He was awarded the Diplomate of the American Board of Anesthesiology of Anesthesiology in 2001 and further board certification in Pain Medicine in 2002. After graduation, Dr. Vallejo joined Millennium Pain Center in Bloomington, Illinois.

The Path from Big Idea to Breakthrough
2020-10-08 17:30 - 18:30
What does it really take to get that big idea to market? Join this engaging conversation with entrepreneurs Eric Grigsby, MD, MBA, CEO and Founder of Neurovations, and David Caraway, MD PhD, CMO from Nevro. There will be plenty of time for questions and answers in this deep dive!

Complimentary Registration

Complimentary Registration

CEO and Founder of Neurovations Dr. Eric Grigsby

Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

David Caraway MD, PhDChief Medical Officer, Nevro

David L. Caraway, MD, PhDChief Medical Officer @NevroDr. Caraway joined Nevro in 2014 as their Chief Medical Officer. Previously, he was the CEO of The Center for Pain Relief, Tri-State, L.L.C., in partnership with St. Mary’s Regional Medical Center in Huntington, West Virginia. Dr. Caraway has maintained an active medical practice for over 20 years and has held leadership positions in the North American Neuromodulation Society (NANS) and the American Society of Interventional Pain Physicians (ASIPP).

As a nationally recognized expert in the treatment of chronic pain, he has lectured regionally, nationally, and internationally in the field of Interventional Pain Medicine and authored numerous publications in this field.

A New Way to Treat Brain Diseases at Home Using Non-Invasive Brain Stimulation
2020-11-05 17:30 - 18:30
Watch the Webinar

The COVID-19 pandemic has highlighted a needs for non-invasive, remote approaches to patient care. Learn how companies like Neuroelectrics are working to bring non-invasive brain stimulation into the home. Join Dr. Eric Grigsby, CEO and Founder of Neurovations, and Ana Maiques, CEO and Co-founder of Neuroelectrics for an engaging conversation on new ways to treat brain diseases at home.

In May 2020, Neuroelectrics received FDA approval for a clinical trial of at-home brain stimulation therapy via telemedicine for patients with Major Depressive Disorder (MDD). An additional trial with Boston Children’s Hospital (IDE G160208) is already underway, studying the therapy for treatment-resistant epilepsy.

Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

Ana Maiques (born 1973) is a Spanish entrepreneur and business executive. She is CEO of Neuroelectrics, Spanish Barcelona-based company which has an office in Cambridge, Massachusetts. It produces devices designed to stimulate and treat the brain. Maiques graduated from the University of North London where she studied European Economics and Social Studies. In 2000, she co-founded and headed Starlab, Barcelona, a neuroscience research company. She developed revolutionary technologies in the fields of space and neuroscience. In 2014, Maiques won third prize in the European Commission’s Women Innovators Contest for her entrepreneurial vision in promoting Starlab as an innovative company of scientific excellence. Now CEO at Neuroelectrics, a Starlab spin-off, Maiquess has developed medical devices for the brain. These are computer applications that are able to help patients overcome chronic pain and depression. Ana Maiques and her husband, Giulio Ruffini, began working in Barcelona for the original Belgian company Starlab. In the year 2000, when the Belgian company declared bankruptcy they, along with Manel Adell, took over the Spanish subsidiary in an attempt to develop marketable products. Maiques is now aiming for Neuroelectrics to become a “leading company in the diagnosis and treatment of brain disorders and diseases of the central nervous system,” while the Spanish Starlab will continue to undertake neuroscience research. In April 2015, Neuroelectrics won the Bupa Startup Stage at Wired Health 2015.

How does your interventional management of headaches compare to the experts?
2021-02-04 17:30
Complimentary Registration

Interventional Headache Management: 2021 Updates

Join Drs. Eric Grigsby and Samer Narouze for a discussion on interventional treatment strategies in headache management.Please submit your questions or share your stories in the comment box below.

Including:1- Cranial parasympathetic innervation and autonomic headache disorders2- Cervicogenic headaches and new targets3- Advances in cranial and peripheral neuromodulation4- New pharmacological classes for headache management

This webinar is co-presented by Neurovations Education and the American Interventional Headache Society (AIHS).

CEO and Founder, Neurovations: A Patient Care and Innovation Company

Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

President @American Interventional Headache Society (AIHS)

Dr. Narouze is board certified in pain medicine, neurology headache medicine, interventional pain management, as well as anesthesiology. He completed his residency in Anesthesiology in 2000 and his Pain Medicine Fellowship in 2002 at Cleveland Clinic Foundation. He received his PhD in cervicogenic headaches from Maastricht University, the Netherlands in 2012. He received the “Master Educator” award from Cleveland Clinic in 2009 and the “Innovator Award” in 2008 for his advancement in the use of minimally invasive techniques used in treating chronic headaches. He recently founded the American Interventional Headache Society (AIHS) and he is on the board of directors for the American Society of Regional Anesthesia and Pain Medicine (ASRA) and serves on many committees for other national and international headache and pain organizations. He frequently speaks and serves as a visiting professor both nationally and internationally.

How to Get Involved in Clinical Research
2021-02-18 17:30 - 18:00
View the Webinar

Including:

Clinicians, especially those in private practice, regularly ask how to break into clinical research.Join two mentor researchers, Drs. Eric J. Grigsby and Leonardo “Leo” Kapural for an overview of the clinical trial process.

– Why get involved in research?– Office infrastructure and personnel needs?– Sponsors: Who pays you to do research?– Is clinical research profitable?– Why would a company, government, or Institution choose your site?

CEO and Founder, Neurovations: A Patient Care and Innovation Company

Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

Leonardo Kapural, MD, PhD

Dr. Leonardo Kapural is a pain physician at the Carolinas Pain Institute and The Center for Clinical Research. He is also a clinical adjunct faculty of anesthesiology at Wake Forest University, School of Medicine. Dr. Kapural’s interests include peripheral nerve stimulation, spinal cord stimulation, discogenic low back pain, and visceral abdominal pain. Following his fellowship in pain management at the Cleveland Clinic, he stayed in the Cleveland Clinic’s pain management department for 10 years, serving also as director of clinical research and professor of anesthesiology at the CCLMC of Case Western University. Dr. Kapural is an active member of a number of professional organizations, including the American Society of Regional Anesthesia and Pain Medicine, North American and International Neuromodulation societies, and World Institute of Pain.

In addition, he is an invited speaker to many national and international meetings. He served as director-at-large of the American Academy of Pain Medicine, and is currently director-at-large of both the North American and International Neuromodulation societies. Dr. Kapural’s experience is broad and encompasses teaching and clinical education and extensive research. His innovation in the area of pain treatments brought him two Innovator Awards. His noteworthy research findings have been published in more than 130 journal articles, more than 200 abstracts, two books, and 30 book chapters. He is listed by his peers in the “Best Doctors in America” list.

The 7th Annual Kaua'i Pain Conference
2021-03-05 08:00 - 2021-03-06 19:30
https://kauaipainconference.com/

Join Us for the 7th Annual Kaua’i Pain Conference

Dr. Grigsby, CEO and Founder of Neurovations, is gifting this virtual experience that provides up to 14.0 AMA PRA Category 1 Credit(s)™ for those who register and participate in the live-streamed event.

KPC connects the best and brightest minds in the fields of pain management and neuroscience with learners and public policy officials. Learn the latest in the treatment of chronic pain and emerging therapies, the winter pain conference.

Complimentary Registration

Chef Demonstration and Wine Pairing with Rocca Family Vineyards
2021-03-06 18:30 - 2021-03-07 19:30
Join us virtually, relax and enjoy a live cooking demonstration of Hawaiian culinary delights paired with Rocca Family Vineyards wines.

Chef Tom Wong, a talented chef from the Culinary Institute of America, will prepare a tantalizing dinner including traditional Hawaiian ingredients, methods, and colorful stories. Wines have been selected by Rocca Winemaker, Paul Colantuoni, matched perfectly with each course, as he takes you through the art of pairing wine and food. We encourage you to sip along while gathering virtual ‘ohana style with your fellow colleagues.

Menu

1st Course“Lomi Salmon”Pan Seared SalmonLomi Lomi Tomato & Sweet Onion RelishOven Roasted KaleTomato Consommé2016 Rocca Family Vineyards Chardonnay, UV Vineyard, Sonoma Coast

2nd Course“Kalua Pig & Cabbage”Stuffed Porchetta with kalua pork, onions, and cabbageIsland Style Succotash – taro, edamame, Okinawan sweet potatoCharred Broccolini, macadamia nut & olive oil rub2016 Rocca Family Vineyards Cabernet Sauvignon, Grigsby Vineyard, Yountville, Napa ValleyRSVP FOR THE RECEPTION

RSVP for the Reception

Integrating Regenerative Medicine into your Interventional Pain Practice
2021-03-27 08:00 - 17:00
Presented by CALSIPP

Earn up to 6 CEU’s while exploring the future of regenerative medicine.

Covid-19 Vaccine Complications-When is it just a headache?
2021-04-19 12:30 - 13:30
Listen to WVOX

Join Dr Ramchandani from the Physiatry Podcast and Dr. Nintin Gupta live in WVOX to discuss the difference between a normal headache vs. a headache from covid-19 vaccine side effect.

Listen to the Physiatry Podcast

2021 Bay Area Global Health Innovation Challenge
2021-05-01 10:15 - 12:15
The Bay Area Global Health Innovation Challenge is a global competition offering student teams from universities worldwide the opportunity to accelerate their ideas for innovative low-cost, high-impact, and scalable global health solutions.

For the final pitch event, the top teams are invited to present their innovations to a panel of judges composed of potential investors, philanthropists, and experts in health, design, and global development, as well as the opportunity to participate in mentoring workshops with leaders from our partner organizations, and network with their peers from around the globe. These teams compete for the grand prize of $10,000 in seed funding, in addition to unique mentorship, idea development, and exposure opportunities.

Register Here

The Bay Area Global Health Innovation Challenge is a competition hosted by the University of California, Berkeley School of Public Health and Stanford Center for Innovation in Global Health in partnership with the UCSF Institute for Global Health Science, UC Davis, the Bay Area Global Health Alliance, and the HealthRoots Foundation for Global Health. We offer student teams from universities worldwide the opportunity to present their ideas for low-cost, high-impact, and scalable global health innovations.

Every year, following an open call for submissions, the top teams are invited to present their innovations to a panel of judges composed of potential investors, philanthropists, and experts in health, design, and global development, as well as the opportunity to participate in mentoring workshops with leaders from our partner organizations, and network with their peers from around the globe. These teams compete for the grand prize of $10,000 in seed funding, and unique mentorship, idea development, and exposure opportunities.

This year’s Challenge partners are world leaders in health, design, tech, and impact investing, who support the Challenge and participating teams in a variety of ways — offering team mentorship and guidance, expert submission reviewers, panelists and workshop leaders at the Challenge in Spring 2021, and more. Stay tuned for an announcement sharing details about our partners.

Past judges have included investors from Kleiner Perkins Caufield & Byers, the founding CEO of Yahoo!, the Chief Strategy Officer of PATH, the President of Global Development at the Bill and Melinda Gates Foundation, the Product Manager for Health at Facebook, designers at IDEO.org, the President and CEO of Bioness, Inc. as well as board members from the Global Health Research Foundation and the International Aids Vaccine Initiative. By participating in the Challenge, student teams will receive the following:

Exposure and sponsorship: Aside from the $10,000 grand prize to the winning team, all finalist teams will have the opportunity to pitch their ideas to high-level judges who are interested in supporting student teams who win them over with funding, mentorship, and other in-kind support opportunities. Mentorship and networking: Finalist teams have the opportunity to network, not only with their peers from around the globe, but also with top Bay Area social investors, philanthropists, and educators who have committed to mentoring student teams through a series of workshops, talks, and one-on-one networking events to be held during the competition.Expert feedback: Ideas will be evaluated by top researchers and scientists in the field of global health hailing from UC Berkeley, Stanford, UCSF, and other Bay Area schools, as well as technology and industry partners.

NIH Pain Consortium: Pre-Clinical and Translational Training Grants
2021-05-13 12:00 - 13:15
#2 in the NIH Pain Consortium Grant-Mechanism Webinar Series

The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH.

There is no cost for these webinars, but attendees must register in advance.

Register

Data-driven Insights to Grow Your Practice
2021-05-27 17:30 - 18:30
COVID-19 has changed the way we practice medicine. Patients are only a few keystrokes away from numerous reviews – some true and, some that are not so true. Join this deep dive into practice management which will focus on reputation management, analytics, and visibility.

Complimentary Registration

Dr. Eric Grigsby, MD, MBA
CEO and Founder of Neurovations

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

Matty Crescenzo, Founder and President, Valet Health

Matty Crescenzo has built upon early career experience as a researcher in neuroscience at the NIH, studying learning & memory through brain imaging modalities such as PET, SPECT, and fMRI. He earned neuroscience and biophysics research awards at the Univ. of Illinois and the UH Texas Center for Superconductivity, prior to pioneering a data-intensive methodology to digital marketing.

His unique expertise helps organizations and leaders seeking an online competitive advantage to quickly adapt to dynamic, fast changing trends across the digital landscape. Matty brings 13+ years of experience in digital marketing and web-based technologies in healthcare and across other industries.

In 2008, Matty developed a robust digital marketing approach which led to the development and sale of a best-selling SEO software suite on Microsoft’s open source platform called DotNetNuke. He authored 120+ premium content and training modules used to educate over 3,000 U.S.-based and international companies on data-driven digital marketing.

NIH Pain Consortium: Early Career Grants
2021-06-10 12:00 - 13:15
#3 in the NIH Pain Consortium Grant-Mechanism Webinar Series

The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH.

There is no cost for these webinars, but attendees must register in advance.

Register

NIH Pain Consortium: Institutional Training Grants
2021-07-08 12:00 - 13:15
#4 in the NIH Pain Consortium Grant-Mechanism Webinar Series

The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH.

There is no cost for these webinars, but attendees must register in advance.

Register

An Intrathecal CRISPR Strategy for Chronic Pain
2021-08-05 17:30 - 18:30
Complimentary Registration

OVERVIEW

Genetic studies have identified in humans key targets pivotal to nociceptive processing. In particular, a hereditary loss-of-function mutation in NaV1.7, a sodium channel protein associated with signaling in nociceptive sensory afferents, leads to insensitivity to pain without other neurodevelopmental alterations.

We investigated targeted epigenetic repression of NaV1.7 in primary afferents via epigenome engineering approaches based on clustered regularly interspaced short palindromic repeats (CRISPR)–dCas9 and zinc finger proteins at the spinal level as a potential treatment for chronic pain.

Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

Ana Moreno is the founder and CEO of Navega Therapeutics. She obtained her Ph.D. from the Bioengineering Department at UCSD , where she spent the last four years developing the platform that enables Navega’s innovative approach.

NIH Pain Consortium: ESI, NI, and Established Investigators
2021-08-12 12:00 - 13:15
#5 in the NIH Pain Consortium Grant-Mechanism Webinar Series

The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH.

There is no cost for these webinars, but attendees must register in advance.

Register

Spinal Cord Stimulation: How it Works for Chronic Pain and When to Use it
2021-08-25 11:30 - 2021-08-26 00:30
Learn more about Neuropathic Pain Therapeutics Digital Summit

Dr. Eric Grigsby, MD, MBA has devoted his life to advancing the diagnosis and treatment of chronic pain. In 1992, Dr. Eric Grigsby founded the Napa Pain Institute. Over 25 years later, he has grown a single, small clinic into Neurovations- a national patient care, and innovation company that includes medical device and pharmaceutical innovation, clinical research, pain and neuroscience education, and community health through the non-profit Foundation, HealthRoots.

Dr. Grigsby attended elementary and secondary school in his hometown of Knoxville, Tennessee, and received a Bachelor’s Degree in Biology and Economics from Brown University in Providence, Rhode Island. He formed an interest in Pain Management as a career while working at Boston Children’s Hospital in the Department of Orthopedic Surgery.

After graduating from Boston University Medical School in 1984, Dr. Grigsby trained in General Surgery, Anesthesiology, and Pain Management at the Mayo Clinic in Rochester, Minnesota. He was then invited to join the Medical Staff and teach at the Mayo Medical School. He moved to California in 1989 where he established the pain management center at UC Davis and served as Medical Director until 1992. Following his post at UC Davis, Dr. Grigsby established Napa Pain Institute in Napa, California. He partnered with wife Dr. Mary Rocca to create Rocca Family Vineyards, a small family producer of award-winning wines in the Napa Valley.

More recently, Dr. Grigsby completed his Master’s in Business Administration from Duke University’s Fuqua School of Business and has provided consultation in market analysis, strategic positioning, sales, product development, and physician training for industry leaders and early-stage companies. Dr. Grigsby speaks nationally on topics including neuromodulation, non-operative treatment of spinal disorders, the safe use of medications for treatment of pain, and the legal and regulatory issues relating to the proper treatment of patients with chronic illness.

Dr. Grigsby continues to practice as a board-certified Pain Physician and is among the world’s clinical leaders in the field of neuromodulation. As CEO and Founder of Neurovations, his unwavering mission is to inspire hope and to contribute to the health and well-being of patients and communities through integrated clinical practice, research, and education.

28th Annual Napa Pain Conference
2021-08-28 08:00 - 17:00
Improve your care for persons with acute and chronic pain.

Since its founding in 1990 by Dr. Eric J. Grigsby, the Napa Pain Conference has set the bar for quality education, breaking research, and networking. Innovation happens here.

Details Coming Soon!

NIH Pain Consortium: Technology Development/Therapeutic Development
2021-09-09 12:00 - 13:15
#6 in the NIH Pain Consortium Grant-Mechanism Webinar Series

The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH.

There is no cost for these webinars, but attendees must register in advance.

Register

NIH Pain Consortium: Clinical Phased Mechanisms
2021-10-14 12:00 - 13:15
#7 in the NIH Pain Consortium Grant-Mechanism Webinar Series

The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH.

There is no cost for these webinars, but attendees must register in advance.

Register

Mechanisms of Closed-loop SCS: 5 Years of Patient Data
2021-10-21 17:30 - 18:30
Complimentary Registration

Overview

Join Drs. Eric J. Grigsby, John Parker, and Lawrence Poree for a conversation on closed-loop spinal cord stimulation (SCS).

What are evoked compound action potentials (ECAPs)? How are they used to create a closed-loop neuromodulation system? What can continuous monitoring the neural responses tell us about the presence and influence of pharmacological agents?

Additional Resources

Brooker, C., Russo, M., Cousins, M. J., Taylor, N., Holford, L., Martin, R., … & Parker, J. (2021). ECAP‐Controlled Closed‐Loop Spinal Cord Stimulation Efficacy and Opioid Reduction Over 24‐Months: Final Results of the Prospective, Multicenter, Open‐Label Avalon Study. Pain Practice.Heijmans, L., & Joosten, E. A. (2020). Mechanisms and mode of action of spinal cord stimulation in chronic neuropathic pain. Postgraduate medicine, 132(sup3), 17-21.Parker, J., Karantonis, D., & Single, P. (2020). Hypothesis for the mechanism of action of ECAP-controlled closed-loop systems for spinal cord stimulation. Healthcare Technology Letters, 7(3), 76-80.

Speakers:

Dr. Lawrence Poree, MD, PhD. MPH, Clinical Professor, Department of Anesthesia, University of California at San Francisco (UCSF)Dr. Eric J. Grigsby, MD, MBA, Founder & CEO, Neurovations: A Patient Care and Innovation CompanyJohn Parker, PhD, Founder and Chief Science Officer, Saluda Medical

Complimentary Registration

Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.

Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.

The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.

Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.

John Parker, PhD, Founder and Chief Scientific Officer, founded the Implant Systems team at NICTA that developed the closed-loop feedback technology. Dr. Parker has over 20 years of experience in medical devices, including 13 years at Cochlear Limited, where he served in the role of Chief Technology Officer / executive member of the board of directors.

Dr. Parker has experience in working in every aspect of commercialization of R&D, from pure research through to full industrialization. John has an academic background (PhD ANU) and has worked in both Australian and international universities. Has authored numerous scientific publications and patents. He is an ATSE fellow, Harvard business School (PMD) graduate, Docent at the Royal Institute of technology in Stockholm Sweden, ATSE Clunies Ross Medallist (2010) and Adjunct Professor UNSW School of Biomedical Engineering.

Lawrence Poree, MD, PhD, MPH began his neuromodulation career as a basic science researcher at UC Berkeley where he investigated the analgesic properties of CNS hormones as part of his doctoral thesis. He continued his research in neuromodulation at Johns Hopkins University in the department of Biomedical Engineering where he investigated the neural pathways involved in spinal cord stimulation and the sympathetic nervous system. He decided to apply his research to medical practice and enrolled at Stanford University where he earned his medical degree and completed his residency in anesthesia while continuing to conduct research on the analgesic properties of alpha-2 agonists. He then completed an interventional pain fellowship at UCSF.

He founded and served as medical director of a private practice comprehensive pain management clinic for the next 15 years. During this time, he consulted for various neuromodulation companies in the development of novel neuromodulation devices. He returned to academia to head the neuromodulation program at the University Of California at San Francisco Pain Management Center.

For the past 8 years he has served on the North American Neuromodulation Society (NANS) Board of Directors.

NIH Pain Consortium: NIH staff roles in the process and high-level overview of before and after grant submission
2021-12-09 12:00 - 13:15
#8 in the NIH Pain Consortium Grant-Mechanism Webinar Series

The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH.

There is no cost for these webinars, but attendees must register in advance.

Register

NIH Pain Consortium: Preparing/writing the application/submitting the grant
2021-12-13 12:00 - 13:15
#9 in the NIH Pain Consortium Grant-Mechanism Webinar Series

The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH.

There is no cost for these webinars, but attendees must register in advance.

Register

NIH Pain Consortium: How to build a budget
2022-02-10 12:00 - 13:15
#10 in the NIH Pain Consortium Grant-Mechanism Webinar Series

The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH.

There is no cost for these webinars, but attendees must register in advance.

Register
